Industrial segment sales increased 5.8 percent in the fourth quarter, the highest-growth segment.
Latest In Pharmaceutical & Health Care
McKesson will exceed the 75% ownership threshold of Celesio through agreements to purchase shares and bonds from two entities.
Profit fell to $41.4 million from $168.6 million a year ago.
Drug distributor failed to reach the 75% completion condition for outstanding shares of Celesio.
The 50/50 venture will source and negotiate generic supply contracts for both companies.
Fein: VMI, vending were pioneered in the sector.
The company was renamed Aesynt upon closing.
Increase due primarily to Owens & Minor’s acquisition of Movianto.
Pharmaceutical declines from expired contracts impacted results.
The company began a new expanded contract with Walgreen Co. during the fourth quarter.
Distribution Solutions sales grew 11 percent in the quarter for McKesson.
Deal expands McKesson’s reach to Europe and results in a more than $150B company.
Celesio is one of Europe’s largest drug distributors.
Adam Fein addresses ACA and other factors impacting the drug distribution channel.
Triplefin is a reimbursement, patient assistance and pharmaceutical brand-support services company.
Manufacturing Revival Radio talks with the editor in chief of Pharmaceutical Manufacturing Magazine.
The business supplies thermal solutions for industrial liquids and gases handling.
For the fourth quarter, sales declined 5 percent from the prior year.
Owens & Minor also announced a change of leadership.
